D. E. Shaw & Co. Inc. Grows Position in Definitive Healthcare Corp. (NASDAQ:DH)

D. E. Shaw & Co. Inc. grew its holdings in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 29.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 709,769 shares of the company's stock after acquiring an additional 161,599 shares during the quarter. D. E. Shaw & Co. Inc. owned 0.61% of Definitive Healthcare worth $2,917,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in DH. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Definitive Healthcare during the fourth quarter worth about $1,181,000. JPMorgan Chase & Co. lifted its holdings in shares of Definitive Healthcare by 431.7% during the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company's stock worth $993,000 after purchasing an additional 180,323 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Definitive Healthcare by 928.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 156,997 shares of the company's stock worth $645,000 after purchasing an additional 141,729 shares during the period. Renaissance Technologies LLC lifted its holdings in shares of Definitive Healthcare by 24.9% during the fourth quarter. Renaissance Technologies LLC now owns 579,440 shares of the company's stock worth $2,381,000 after purchasing an additional 115,389 shares during the period. Finally, XTX Topco Ltd lifted its holdings in shares of Definitive Healthcare by 467.3% during the fourth quarter. XTX Topco Ltd now owns 118,506 shares of the company's stock worth $487,000 after purchasing an additional 97,617 shares during the period. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock traded down $0.11 on Friday, reaching $3.02. The company's stock had a trading volume of 441,056 shares, compared to its average volume of 818,253. The company has a market capitalization of $448.90 million, a P/E ratio of -0.97, a PEG ratio of 4.06 and a beta of 1.48. Definitive Healthcare Corp. has a 52-week low of $2.15 and a 52-week high of $6.27. The stock has a 50-day moving average price of $2.82 and a 200-day moving average price of $3.81. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. The business had revenue of $59.19 million during the quarter, compared to analysts' expectations of $56.20 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The business's revenue was down 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.08 earnings per share. Analysts expect that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Barclays decreased their target price on Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a report on Monday, March 3rd. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Thursday. The Goldman Sachs Group boosted their price target on Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a report on Monday, May 12th. Finally, BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $5.10.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.